IRVINE, Calif.--(BUSINESS WIRE)--Spectrum Pharmaceuticals (NasdaqGM: SPPI), a commercial-stage biotechnology company with two proprietary, FDA-approved oncology drugs on the market, announced the results of its annual meeting of shareholders, which was held today at the Company’s global corporate headquarters in Irvine, California.
